Gynecology Oncology
Nadereh Behtash; Fahimeh Sabet; Narges Izadi-mood; Mojgan Karimi-Zarchi
Volume 6, Issue 1 , January 2021, , Pages 42-49
Abstract
Vulvar Paget’s disease is rare among patients with vulvar cancer. Commonly, this disease is presented in the vulva and seen in postmenopausal women. In this study, we reported five cases of vulvar Paget’s disease referred to Bahman Hospital, Tehran, Iran, from 2013 to 2019. The median ...
Read More
Vulvar Paget’s disease is rare among patients with vulvar cancer. Commonly, this disease is presented in the vulva and seen in postmenopausal women. In this study, we reported five cases of vulvar Paget’s disease referred to Bahman Hospital, Tehran, Iran, from 2013 to 2019. The median age of patients diagnosed with Paget’s vulvar disease was 56.2 years (ranges from 52 to 62 years); the oncology history of patients was negative. All patients underwent surgery, including wide local excision, hemivulvectomy, and bilateral vulvectomy. The invasive disease was observed in three patients. Surgical margins in three patients were involved by Paget’s disease, and one recurrence (25%) was observed. Paget’s disease should be diagnosed and treated by surgery as soon as possible to avoid worsening the prognosis of patients and recurrence.
Mojgan Karimi Zarchi; Abolfazl Mehdizadeh Kashi; Leila Allahqoli; Razieh Sadat Tabatabai; Farimah Shamsi; Nafiseh Hashemian Asl
Volume 4, Issue 2 , May and June 2019, , Pages 57-61
Abstract
Background & Objective: This study investigated the recurrence and survival rates of patients with borderline ovarian tumors in Yazd in the last 10 years.
Materials & Methods: This census survival study was performed on 24 patients with borderline ovarian tumors who referred to hospitals ...
Read More
Background & Objective: This study investigated the recurrence and survival rates of patients with borderline ovarian tumors in Yazd in the last 10 years.
Materials & Methods: This census survival study was performed on 24 patients with borderline ovarian tumors who referred to hospitals affiliated to Yazd University of Medical Sciences from 2006 to 2016. A data collection checklist was used as a measurement tool and was completed by the researcher by reviewing the subjects’ medical records. The questionnaire included age, infertility, the number of delivery, contraceptive use, body mass index, time of diagnosis, time to start the treatment, whether alive or not, stage of the disease, the type of pathology, the type of surgery, and postoperative treatment. Data was analyzed by SPSS 16 using descriptive statistics.
Results: The mean age of these 24 patients was 33.58±10.61 and the mean recurrence time was 14±2 months. Sixteen (66.7%) patients had serous tumors and 8 (33.3%) patients had mucinous tumors. Among them, 18 (75%) patients underwent a hysterectomy, 2 (8.3%) patients underwent an oophorectomy and 4 (16.7%) patients underwent both total abdominal hysterectomy (TAH) and oophorectomy. Of the 24 studied patients, 4 patients (16.7%) received medicinal treatment (clomiphene citrate, HCG, HMG) after surgery. Three patients experienced recurrences, all in the contralateral ovary.
Conclusion: The recurrence time of epithelial borderline ovarian tumor was 14±2 months. There was no significant relationship between postoperative medicinal treatment and the recurrence rate.
Mojgan Karimi Zarchi; Soraya Teimoori
Volume 2, Issue 4 , November and December 2017, , Pages 1-2
